1. Ministério da Saúde B.R. Anticoncepção hormonal oral. Assistência em planejamento familiar (bvsms.saude.gov.br/bvs//publicações/0102assistencia2. 4ª Edição, Série A, Normas e Manuais Técnicos; n. 40. Brasília – DF, 2002. 〈http://www.bvsms.saude.gov.br/bvs/publicacoes/0102assistencia1〉 (accessed 17 May 2019).
2. "The Top 300 of 2019". Retrieved December 22, 2018. 〈http://www.clincalc.com〉 (accessed 27 Dec 2019).
3. National Center for Biotechnology Information. PubChem Database. 〈http://www.pubchem.ncbi.nlm.nih.gov〉 (accessed 27 December 2019).
4. ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use). Guideline for Impurities in New Drug Products Q3B(R2), 2006. 〈http://www.ema.europa.eu/en/ich-q3b-r2-impurities-new-drug-products〉 (accessed 20 January 2021).
5. ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use). Validation of Analytical Procedures: Text and Methodology. Q2 (R1), 2005. 〈http://www.fda.gov/regulatory-information/search-fda-guidance-doccuments/q2r1-validation-analytical-procedures-text-and-methodology-guidance-industry〉 (accessed 20 January 2021).